S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ImmutepAdamas PharmaceuticalsRockwell MedicalLifeVantageChembio Diagnostics
SymbolNASDAQ:IMMPNASDAQ:ADMSNASDAQ:RMTINASDAQ:LFVNNASDAQ:CEMI
Price Information
Current Price$2.68$4.75$1.35$8.75$5.56
52 Week RangeBuyBuyBuyN/AHold
MarketRank™
Overall Score1.31.51.31.01.3
Analysis Score3.53.43.50.03.2
Community Score2.92.72.42.72.5
Dividend Score0.00.00.00.00.0
Ownership Score0.00.80.00.80.0
Earnings & Valuation Score0.00.60.61.30.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/AHold
Consensus Price Target$7.00$12.25$5.50N/A$7.10
% Upside from Price Target161.19% upside157.89% upside307.41% upsideN/A27.70% upside
Trade Information
Market Cap$104.52 million$145.20 million$126.32 million$123.96 million$112.18 million
Beta2.232.961.111.422.05
Average Volume853,189924,7182,387,424100,1111,005,059
Sales & Book Value
Annual Revenue$4.92 million$54.64 million$61.30 million$232.91 million$34.46 million
Price / Sales21.242.662.060.533.26
CashflowN/AN/AN/A$1.18 per shareN/A
Price / CashN/AN/AN/A7.44N/A
Book Value$0.57 per share($0.03) per share$0.32 per share$2.32 per share$1.37 per share
Price / Book4.70-158.334.223.774.06
Profitability
Net Income$-9,040,000.00$-105,190,000.00$-34,130,000.00$11.55 million$-13,680,000.00
EPSN/A($3.80)($0.56)$0.86($0.79)
Trailing P/E Ratio0.00N/AN/A10.42N/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-89.12%-47.23%5.29%-76.55%
Return on Equity (ROE)N/AN/A-117.67%45.39%-73.70%
Return on Assets (ROA)N/A-43.47%-46.33%24.01%-33.21%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.26%N/A0.50%N/A0.54%
Current Ratio9.26%3.94%6.13%1.86%4.07%
Quick Ratio9.26%3.72%5.83%1.19%2.97%
Ownership Information
Institutional Ownership Percentage0.16%44.23%26.72%46.68%31.06%
Insider Ownership PercentageN/A19.70%4.70%9.80%3.00%
Miscellaneous
EmployeesN/A136299247324
Shares Outstanding39.00 million30.57 million93.57 million14.17 million20.18 million
Next Earnings DateN/A5/6/2021 (Estimated)3/11/2021 (Estimated)5/4/2021 (Estimated)3/11/2021 (Confirmed)
OptionableNot OptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.